Main board

SCIENTIFIC EVENT

If you want, you can send details about your upcoming scientific event by filling out the form on our Scientific events web site www.arpharm-e4ethics.org.

Send

Dr. Krasimira Chemishanska - Amgen

CHAIRPERSON

Dr. Krassimira Chemishanska is the General Manager of Amgen Bulgaria since the opening of the affiliate in 2009. Prior to her appointment at Amgen Bulgaria, she worked at different management positions in AstraZeneca Bulgaria, the last one being Marketing Director.

Dr. Krassimira Chemishanska graduated Medicine from the Medical University in Sofia and has acquired a MBA in General Management from the City University of Seattle and a Master Degree in Business Administration from the International Business School.

Since 2013 she is member of ARPharM Board, and since 2011 member of the AmCham Board of Directors.

In 2015 she is elected for a President of American Chamber of Commerce.

Dr. Svetoslav Tsenov - Astellas Bulgaria

VICE-CHAIRPERSON

Dr. Svetoslav Tsenov is a Director of Astellas for Bulgaria, Romania and Hungary.

He is a business leader with more than 12 years of experience in the pharmaceutical industry.

He has taken different senior positions in Bulgaria and Central and Eastern Europe in marketing, medical, market access, government affairs and general management roles in multinational companies.

Dr. Svetoslav Tsenov has graduated Medicine from the Medical University of Sofia, followed by a Master Degree in Finance.

Dr. Lisa Bonadonna - GSK Bulgaria

BOARD MEMBER

Dr. Lisa Bonandonna has been in a number of positions with growing responsibility at local, regional and global level in GSK. She has held commercial roles both in Australia and in Italy and has managed company’s global adult vaccines portfolio. In 2012, Lisa joined GSK's CGA Team as Vice President, leading the negotiations for the first agreement signed between the industry and the WHO under the Pandemic Influenza Preparedness Framework.

Prior to taking over as GM of GSK Bulgaria in July 2018, she was the Global Lead of GSK-Save the Children's partnership and access to GSK's medicinal products portfolio. Lisa has a PhD in immunology from the University of Melbourne, Australia, MBA in Public Health Policy from LSE and a Master’s Degree in Business from Melbourne Business School.

Dr. Ana Tsakova - Merck Bulgaria

BOARD MEMBER

Dr. Ana Tsakova is Managing Director of Merck Bulgaria since 2016. She has 20 years of experience in the pharmaceutical industry, starting her career at MSD as Medical representative. In 2007 she continued her professional experience in Actavis EAD and in 2011 she joined the team of Merck Bulgaria, taking the lead of it later on in 2016. She has held various positions in marketing, sales and management, growing in accountability, being responsible for businesses across different fields of medicine.

Dr. Ana Tsakova is a medical doctor with a degree from the Medical University Sofia in 1999 and later obtained her Ph.D. in Pharmacology in the Department of Pharmacology and Toxicology in the same University. In 2004 she obtained an MBA degree from the Sofia University's Faculty of Economics. Her interests are in the fields of medicine, healthcare and innovation.

Mr. Konstantinos Papagiannis - MSD (Merck Sharp & Dohme)

BOARD MEMBER

Konstantinos Papagiannis is currently Managing Director for the American Pharmaceutical Company, MSD (Merck Sharm & Dohme), in Bulgaria. Prior arriving in Bulgaria (April 2018) Konstantinos held various roles at MSD Greece, lately leading Specialty & Hospital Care Business Unit.

Konstantinos has a very diverse professional background, sector and region wise, as prior MSD his professional experience was with Fast Moving Consumer Goods and companies as SC Johnson, Kellogg, & General Mills. He held various Commercial roles across Europe, CEE and Middle East Region and lived in UK and Switzerland for a certain period.

Born and raised in Greece and educated in the UK being a graduate with BA (Hons) in Marketing from Middlesex University in London.

Since December 2018 he is an elected member of the board of American Chamber of commerce in Bulgaria and member of the Executive committee as Chamber’s Treasurer.

Dr. Mila Eliseeva - Pfizer

BOARD MEMBER

Dr. Mila Eliseeva is the Country Manager and Internal Medicines Business Lead for Pfizer Bulgaria and Ukraine.

Mila Elisseeva has 20 years of professional experience in the pharmaceutical industry. She joins Pfizer Bulgaria in February, 2011 as Vaccines Lead followed by the position of Business Unit Manager Specialty Products and Vaccines.

Mila has been responsible for the management of the company in Bulgaria as Country Manager & Business Lead Global Innovative Products since February, 2014. Before joining Pfizer she has been working at various leadership positions for Sanofi Bulgaria.

Mila is a member of the managing board of the Bulgarian Industrial Association and as of April, 2019 is also a member of the main board of ARPharM.

Mr. Emilio Gagliardi - Servier

BOARD MEMBER

Emilio Gagliardi is the new General Manager of Servier Bulgaria since October 2019.

He has been working for 20 years in the pharma industry covering different management responsibilities in Sales and Marketing. He has a global experience having been working and living in many different countries in Europe and Latin America.

Before joining Servier Group he has been working in different leadership positions for Astra Zeneca.

Emilio Gagliardi has a degree of Molecular Biology from the University of Florence, Italy and a master in Finance.

He has interest in sociology and he is deeply passionate by communication skills.

Mr. Deyan Denev

DIRECTOR OF ARPharM

Mr. Deyan Denev is heading the Association of Research-based Pharmaceutical Manufacturers in Bulgaria since October 2003. He has a legal education from Sofia University and is an expert in pharmaceutical legislation and pharmaceutical policy. As Director of the association he is leading the advocacy activities of R&D pharmaceutical industry in Bulgaria on key issues regarding pharmaceutical policy, regulatory environment, intellectual property, pharmaceutical market development.

From Jan. 2008 till Feb. 2013 he is a representative of the pharmaceutical industry in the Transparency Commission, which is an appeal body for all piecing and reimbursement decisions in Bulgaria.

Members of the Association